Clinical trial
The Effect of Fasudil on Vascular Function in Humans
NCT00120718 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00120718 |
|---|---|
| Title | The Effect of Fasudil on Vascular Function in Humans |
| Official title | The Effect of Fasudil on Vascular Function in Humans |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Atherosclerosis, Hypercholesterolemia |
| Intervention type | Drug |
| Interventions | fasudil |
| Enrollment | 60 |
| Start date | Jun 1, 2002 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Jul 19, 2005 |
| Last update posted | Sep 30, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: